Spinoff spurs Canadian retail giant

Spinoff spurs Canadian retail giant

This company recently transferred its majority stake in Canada’s leading REIT to its parent company. As a result of that reorganization, it can now focus exclusively on expanding profits for its main retailing operations.

For example, the company recently launched a new enhanced delivery program modelled… Read More

Dividend Advisor Hotline – Friday, January 4, 2019

PFIZER INC., $43.00, New York symbol PFE, is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis).

Starting with the March 2019 payment, Pfizer will increase its quarterly dividend by 5.9%,… Read More